A new technology for manipulating expression levels of Geminin during a specific period and also at a specific level, i. e., CP-Geminin, could help further elucidate the role of Geminin in stem cells and cancer cells, and could also provide a new tool for controlling their activity. The gene discussed is GMNN; the disease is cancer.